Endocrine dysfunctions in patients treated for brain tumors: Incidence and guidelines for management

Alba Ariela Brandes, Lara Maria Pasetto, Franco Lumachi, Silvio Monfardini

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Endocrine alterations are frequently found in patients undergoing treatment for CNS tumors. Careful follow-up aimed at the early detection of recurrences, with life-long monitor of hypothalamus-pituitary (HP) function, will also reveal any endocrine dysfunctions; indeed, their appropriate diagnosis and treatment may determine a significant improvement in the quality of life of these patients.

Original languageEnglish
Pages (from-to)85-92
Number of pages8
JournalJournal of Neuro-Oncology
Volume47
Issue number1
DOIs
Publication statusPublished - 2000

Fingerprint

Brain Neoplasms
Guidelines
Incidence
Hypothalamus
Quality of Life
Recurrence
Therapeutics
Neoplasms

Keywords

  • Brain tumors
  • Endocrine dysfunction
  • Late effects
  • Long-term survivors
  • Review

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Endocrine dysfunctions in patients treated for brain tumors : Incidence and guidelines for management. / Brandes, Alba Ariela; Pasetto, Lara Maria; Lumachi, Franco; Monfardini, Silvio.

In: Journal of Neuro-Oncology, Vol. 47, No. 1, 2000, p. 85-92.

Research output: Contribution to journalArticle

Brandes, Alba Ariela ; Pasetto, Lara Maria ; Lumachi, Franco ; Monfardini, Silvio. / Endocrine dysfunctions in patients treated for brain tumors : Incidence and guidelines for management. In: Journal of Neuro-Oncology. 2000 ; Vol. 47, No. 1. pp. 85-92.
@article{5893e6cb077e4a079d2996629a7d0926,
title = "Endocrine dysfunctions in patients treated for brain tumors: Incidence and guidelines for management",
abstract = "Endocrine alterations are frequently found in patients undergoing treatment for CNS tumors. Careful follow-up aimed at the early detection of recurrences, with life-long monitor of hypothalamus-pituitary (HP) function, will also reveal any endocrine dysfunctions; indeed, their appropriate diagnosis and treatment may determine a significant improvement in the quality of life of these patients.",
keywords = "Brain tumors, Endocrine dysfunction, Late effects, Long-term survivors, Review",
author = "Brandes, {Alba Ariela} and Pasetto, {Lara Maria} and Franco Lumachi and Silvio Monfardini",
year = "2000",
doi = "10.1023/A:1006471405435",
language = "English",
volume = "47",
pages = "85--92",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "1",

}

TY - JOUR

T1 - Endocrine dysfunctions in patients treated for brain tumors

T2 - Incidence and guidelines for management

AU - Brandes, Alba Ariela

AU - Pasetto, Lara Maria

AU - Lumachi, Franco

AU - Monfardini, Silvio

PY - 2000

Y1 - 2000

N2 - Endocrine alterations are frequently found in patients undergoing treatment for CNS tumors. Careful follow-up aimed at the early detection of recurrences, with life-long monitor of hypothalamus-pituitary (HP) function, will also reveal any endocrine dysfunctions; indeed, their appropriate diagnosis and treatment may determine a significant improvement in the quality of life of these patients.

AB - Endocrine alterations are frequently found in patients undergoing treatment for CNS tumors. Careful follow-up aimed at the early detection of recurrences, with life-long monitor of hypothalamus-pituitary (HP) function, will also reveal any endocrine dysfunctions; indeed, their appropriate diagnosis and treatment may determine a significant improvement in the quality of life of these patients.

KW - Brain tumors

KW - Endocrine dysfunction

KW - Late effects

KW - Long-term survivors

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=0033910172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033910172&partnerID=8YFLogxK

U2 - 10.1023/A:1006471405435

DO - 10.1023/A:1006471405435

M3 - Article

C2 - 10930105

AN - SCOPUS:0033910172

VL - 47

SP - 85

EP - 92

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -